Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 18, 2023

SELL
$1.2 - $2.73 $822 - $1,870
-685 Reduced 97.44%
18 $0
Q4 2022

Jan 13, 2023

BUY
$1.71 - $3.61 $774 - $1,635
453 Added 181.2%
703 $0
Q3 2022

Oct 18, 2022

BUY
$1.9 - $8.63 $475 - $2,157
250 New
250 $1,000
Q2 2022

Jul 13, 2022

SELL
$2.13 - $9.01 $48 - $207
-23 Closed
0 $0
Q1 2022

Apr 22, 2022

BUY
$6.28 - $15.59 $144 - $358
23 New
23 $0

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.